Total Payments
$10,169
2024 Payments
$1,837
Companies
24
Transactions
417
Medicare Patients
6,227
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$5,970 (58.7%)
Other$4,000 (39.3%)
Education$199.14 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,970 | 409 | 58.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,000 | 2 | 39.3% |
| Education | $199.14 | 6 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $5,006 | 122 | $0 (2024) |
| ABBVIE INC. | $1,855 | 100 | $0 (2024) |
| Janssen Biotech, Inc. | $672.03 | 47 | $0 (2024) |
| GlaxoSmithKline, LLC. | $535.83 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $530.91 | 38 | $0 (2024) |
| PFIZER INC. | $464.41 | 34 | $0 (2024) |
| Amgen Inc. | $427.76 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $142.92 | 7 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $108.13 | 4 | $0 (2024) |
| UCB, Inc. | $64.92 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,837 | 95 | ABBVIE INC. ($695.57) |
| 2023 | $1,307 | 59 | AbbVie Inc. ($455.40) |
| 2022 | $772.91 | 43 | ABBVIE INC. ($377.49) |
| 2020 | $87.73 | 6 | Novartis Pharmaceuticals Corporation ($29.43) |
| 2019 | $5,068 | 96 | Genentech USA, Inc. ($4,467) |
| 2018 | $390.59 | 44 | Genentech USA, Inc. ($156.84) |
| 2017 | $705.74 | 74 | Genentech USA, Inc. ($254.28) |
All Payment Transactions
417 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | XARELTO (Drug) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $27.67 | General |
| 10/24/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Bone Health | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: Immunology | ||||||
| 10/15/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,772 | 10,450 | $1.1M | $383,098 |
| 2022 | 23 | 1,798 | 65,294 | $2.6M | $827,863 |
| 2021 | 19 | 1,311 | 9,748 | $1.2M | $277,752 |
| 2020 | 27 | 1,346 | 13,032 | $1.7M | $503,085 |
Total Patients
6,227
Total Services
98,524
Medicare Billing
$2.0M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 11 | 3,037 | $514,227 | $184,579 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 477 | 853 | $213,250 | $74,740 | 35.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 38 | 3,720 | $126,480 | $67,313 | 53.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 43 | 278 | $139,000 | $27,527 | 19.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 323 | 615 | $6,150 | $5,125 | 83.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 265 | 512 | $12,800 | $3,883 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $12,375 | $3,846 | 31.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 20 | 152 | $45,600 | $3,238 | 7.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 51 | $17,850 | $2,449 | 13.7% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 240 | 449 | $11,225 | $1,870 | 16.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 48 | 48 | $5,760 | $1,744 | 30.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 30 | $9,900 | $1,559 | 15.7% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 19 | 35 | $2,275 | $1,005 | 44.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 82 | $4,100 | $896.54 | 21.9% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 19 | 19 | $2,356 | $687.89 | 29.2% |
| 73521 | X-ray of both hips, 2 views | Office | 2023 | 15 | 23 | $2,760 | $655.86 | 23.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 14 | 42 | $3,360 | $503.16 | 15.0% |
| 72050 | X-ray of upper spine, 4-5 views | Office | 2023 | 12 | 12 | $1,032 | $499.80 | 48.4% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 16 | 80 | $8,000 | $486.23 | 6.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 11 | $682.00 | $289.41 | 42.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 54 | 321 | $8,346 | $162.51 | 1.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 32 | 47 | $517.00 | $38.47 | 7.4% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2022 | 11 | 46,663 | $401,233 | $216,053 | 53.8% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 11 | 5,625 | $556,875 | $194,994 | 35.0% |
| J9312 | Injection, rituximab, 10 mg | Office | 2022 | 12 | 1,823 | $307,994 | $121,032 | 39.3% |
About Dr. Aixa Toledo-Garcia, M.D
Dr. Aixa Toledo-Garcia, M.D is a Specialist healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891956751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aixa Toledo-Garcia, M.D has received a total of $10,169 in payments from pharmaceutical and medical device companies, with $1,837 received in 2024. These payments were reported across 417 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($5,970).
As a Medicare-enrolled provider, Toledo-Garcia has provided services to 6,227 Medicare beneficiaries, totaling 98,524 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Rheumatology
- Location Albany, NY
- Active Since 06/23/2008
- Last Updated 04/22/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1891956751
Products in Payments
- Actemra (Biological) $4,328
- RINVOQ (Biological) $1,184
- Rituxan (Biological) $657.54
- BENLYSTA (Biological) $535.83
- XELJANZ (Drug) $440.39
- TREMFYA (Drug) $357.51
- SKYRIZI (Biological) $327.56
- COSENTYX (Biological) $306.88
- Humira (Biological) $222.61
- SIMPONI ARIA (Biological) $199.86
- COSENTYX (Drug) $180.77
- ORENCIA (Biological) $142.92
- KRYSTEXXA (Biological) $116.83
- ACTHAR (Biological) $108.13
- EVENITY (Biological) $88.69
- STELARA (Biological) $82.09
- Enbrel (Biological) $72.14
- Cimzia (Drug) $64.92
- TAVNEOS (Drug) $60.36
- Rinvoq (Biological) $59.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Albany
Dr. Joel Kremer, M.d, M.D
Specialist — Payments: $321,309
Specialist $321,309
Dorota Hausner-Sypek, M.d, M.D
Specialist — Payments: $14,460
Specialist $14,460
Dr. Neal Greenstein, M.d, M.D
Specialist — Payments: $11,279
Specialist $11,279
Rahul Patel, M.d, M.D
Specialist — Payments: $8,936
Specialist $8,936
Dr. Susan Gannon, M.d, M.D
Specialist — Payments: $8,194
Specialist $8,194
Robert Engle, M.d, M.D
Specialist — Payments: $6,695
Specialist $6,695